CUBIST PHARMACEUTICALS LLC – Trademark Portfolio
Entity Type: 16
CUBIST PHARMACEUTICALS LLC holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 8 filings in this category. The portfolio also extends into Class 36 (Insurance & Financial) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include Z. The owner is based in KENILWORTH, NJ.
2000 GALLOPING HILL ROAD
KENILWORTH, NJ 07033
Showing of trademarks Trademarks
Trademark Classifications
CUBIST PHARMACEUTICALS LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Insurance; financial affairs; monetary affairs; real estate affairs
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does CUBIST PHARMACEUTICALS LLC have?
CUBIST PHARMACEUTICALS LLC has 9 U.S. trademarks filed with the USPTO. Of these, 2 registered, 6 abandoned, 1 cancelled.
What trademark classes does CUBIST PHARMACEUTICALS LLC file in?
CUBIST PHARMACEUTICALS LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 36 (Insurance & Financial), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are CUBIST PHARMACEUTICALS LLC's most well-known trademarks?
CUBIST PHARMACEUTICALS LLC's registered trademark portfolio includes well-known marks such as Z. These are among 2 currently registered trademarks in the portfolio.
What is CUBIST PHARMACEUTICALS LLC's trademark registration success rate?
CUBIST PHARMACEUTICALS LLC has a 22% trademark registration rate, with 2 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.